Wipro, Strides Pharma Science, and Diamond Power Infrastructure are among the big businesses that have planned big corporate events this week, including buybacks, stock splits, and dividends. The article lists the record dates for stock splits, bonus issues, share buybacks, and dividend payments to shareholders.
Monday, December 2, 2024 is the planned day for the following corporate actions:A 1:3 bonus issue has been announced by Rajoo Engineers Ltd., meaning that shareholders would get one extra share for every three shares they now own.
Tuesday, December 3, 2024 is set aside for the following corporate actions:
The stock of Diamond Power Infrastructure Limited will be divided (ex-date), with a split ratio of 10:1, and the face value of each share will be changed from ₹10 to ₹1. This implies that if you own one share of the business with a face value of ₹10, you will get ten shares with a face value of ₹1 each following the split.
The Rights Issue of Equity Shares Gujarat Natural Resources Limited is scheduled to commence on December 12 and finish on December 24 at a price of ₹10 per share. The record date is December 3, 2024. The ratio of the rights issue is 3:5. This implies that for every five shares you own, you can buy three more.
With a bonus ratio of 1:1, Wipro Ltd. has announced a bonus issue in which shareholders would get one more share for each share they now own.
On the record date of December 3, 2024, Indo Us Bio-Tech Ltd would pay an interim dividend of ₹0.25 per share, based on the face value of ₹10 per share.
A rights issue of equity shares with a record date of December 3, 2024, has been launched by Moongipa Capital Finance Ltd. The rights issue, which will sell shares at ₹25 each, will begin on December 12 and finish on December 27. The ratio of the rights issue is 2:1. This implies that for every share you own, you can buy two more.
This Wednesday, December 4, 2024, will see the following corporate actions:
On December 4, 2024, Can Fin Homes Ltd. will turn ex-dividend and pay an interim dividend of ₹6 per share on a face value of ₹2.
The following corporate actions will occur on Thursday, December 5, 2024:
This Wednesday, December 4, 2024, will see the following corporate actions:
On December 4, 2024, Can Fin Homes Ltd. will turn ex-dividend and pay an interim dividend of ₹6 per share on a face value of ₹2.
The following corporate actions will occur on Thursday, December 5, 2024:
On or before the ex-date, Tara Chand InfraLogistic Solutions Ltd.'s shares will be split, with a 5:1 split ratio and a face value change from ₹10 to ₹2 per share. This implies that if you own one share of the business with a face value of ₹10, you will get five shares with a value of ₹2 each following the split.
The following corporate actions will occur on Friday, December 6, 2024:
With a bonus ratio of 1:1, Consecutive Investment & Trading Company Ltd. has announced a bonus issue in which shareholders will get one extra share for every share they currently own. Additionally, the business will split its stock (ex-date), lowering the face value of each share from ₹10 to ₹1, using a 10:1 split ratio. Thus, if you have one.
With a split ratio of 10:1, Eraaya Lifespaces Ltd.'s shares will be divided on the ex-date, with each share's face value going from ₹10 to ₹1. This implies that if you own one share of the business with a face value of ₹10, you will get ten shares with a face value of ₹1 each following the split.
For each share held on a record date of December 6, 2024, Phoenix Township Ltd. will pay an interim dividend of ₹2.25 per share on a face value of ₹10.
A spin-off incorporating Strides Pharma Science Ltd.'s CDMO and soft gelatin businesses has been announced. Stelis Biopharma will be the new name for these parts. As part of this reorganization, Steriscience's CDMO division will also be included into Stelis. The date of record for this corporate action is set for December 6, 2024.
For each share held on a record date of December 6, 2024, Phoenix Township Ltd. will pay an interim dividend of ₹2.25 per share on a face value of ₹10.
A spin-off incorporating Strides Pharma Science Ltd.'s CDMO and soft gelatin businesses has been announced. Stelis Biopharma will be the new name for these parts. As part of this reorganization, Steriscience's CDMO division will also be included into Stelis. The date of record for this corporate action is set for December 6, 2024.
0 Comments